Literature DB >> 31808857

Evidence-Based Minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignancies.

Richard J Lin1, Heidi D Klepin2.   

Abstract

A 65-year-old women was diagnosed with acute myeloid leukemia (AML; normal cytogenetics, NPM1 mutated, FLT3-ITD wild type). Preinduction screening geriatric assessment (GA) did not reveal any significant deficit, because she was independent of basic activities of daily living (ADLs) and instrumental activities of daily living (IADLs), had normal cognition, and scored 10 (range 0-12) on the short physical performance battery (SPPB). She underwent standard 7 + 3 induction and achieved a complete remission, although her course was complicated by neutropenic sepsis and bacteremia. She is being evaluated for postremission therapy. Would you recommend a follow-up GA at this time?
© 2019 by The American Society of Hematology. All rights reserved.

Entities:  

Mesh：

Year:  2019        PMID： 31808857      PMCID： PMC6913508          DOI： 10.1182/hematology.2019000076

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN： 1520-4383


  14 in total

Review 1.  What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.

Authors:  Annalynn M Williams; Clive S Zent; Michelle C Janelsins
Journal:  Br J Haematol       Date:  2016-07-08       Impact factor: 6.998

2.  Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale.

Authors:  S Bonanad; J De la Rubia; M Gironella; E Pérez Persona; B González; C Fernández Lago; M Arnan; M Zudaire; J A Hernández Rivas; A Soler; C Marrero; C Olivier; A Altés; D Valcárcel; M T Hernández; I Oiartzabal; R Fernández Ordoño; M Arnao; A Esquerra; J Sarrá; E González-Barca; J González; X Calvo; M Nomdedeu; A García Guiñón; A Ramírez Payer; A Casado; S López; M Durán; M Marcos; A J Cruz-Jentoft
Journal:  J Geriatr Oncol       Date:  2015-06-29       Impact factor: 3.599

3.  Geriatric Oncology: Getting Even Better with Age.

Authors:  Heidi D Klepin; Tanya M Wildes
Journal:  J Am Geriatr Soc       Date:  2019-04-22       Impact factor: 5.562

4.  How cancer therapeutics cause accelerated aging: Insights from the hallmarks of aging.

Authors:  Addie Hill; Jaya Sadda; Mark A LaBarge; Arti Hurria
Journal:  J Geriatr Oncol       Date:  2019-03-21       Impact factor: 3.599

5.  Geriatric assessment in acute myeloid leukemia: current and future landscape.

Authors:  Kah Poh Loh; Heidi D Klepin
Journal:  Blood Adv       Date:  2018-09-25

6.  Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients.

Authors:  Lori S Muffly; Masha Kocherginsky; Wendy Stock; Quynh Chu; Michael R Bishop; Lucy A Godley; Justin Kline; Hongtao Liu; Olatoyosi M Odenike; Richard A Larson; Koen van Besien; Andrew S Artz
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

Review 7.  Frailty and the management of hematologic malignancies.

Authors:  Gregory A Abel; Heidi D Klepin
Journal:  Blood       Date:  2017-11-15       Impact factor: 22.113

8.  Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis.

Authors:  Barbara Deschler; Gabriele Ihorst; Susanne Schnitzler; Hartmut Bertz; Juergen Finke
Journal:  Bone Marrow Transplant       Date:  2018-01-12       Impact factor: 5.483

9.  Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age.

Authors:  Shabbir M H Alibhai; Henriette Breunis; Narhari Timilshina; Romina Brignardello-Petersen; George Tomlinson; Hassanabbas Mohamedali; Vikas Gupta; Mark D Minden; Madeline Li; Rena Buckstein; Joseph M Brandwein
Journal:  J Geriatr Oncol       Date:  2015-05-02       Impact factor: 3.599

10.  Further psychometric validation of the GAH scale: Responsiveness and effect size.

Authors:  Alfonso José Cruz-Jentoft; Bernardo González; Javier de la Rubia; José Ángel Hernández Rivas; Juan Alfonso Soler; Carlos Fernández Lago; Mario Arnao; Mercedes Gironella; Ernesto Pérez Persona; María Teresa Zudaire; Carmen Olivier; Alberto Altés; Antonio García Guiñón; Benet Nomdedeu; Montserrat Arnan; Ángel Ramírez Payer; Pedro Sánchez-Godoy; Nuria Pajuelo; David Vilanova; Diego Fernánez Monjil; Santiago Bonanad
Journal:  J Geriatr Oncol       Date:  2016-12-22       Impact factor: 3.599
View more
  3 in total

1.  Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatment.

Authors:  Hira Mian; Gregory R Pond; Sascha A Tuchman; Mark A Fiala; Tanya M Wildes
Journal:  J Geriatr Oncol       Date:  2020-05-27       Impact factor: 3.599

2.  Gait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatment.

Authors:  Andrew Hantel; Clark DuMontier; Oreofe O Odejide; Marlise R Luskin; Adam S Sperling; Tammy Hshieh; Richard Chen; Robert Soiffer; Jane A Driver; Gregory A Abel
Journal:  Cancer       Date:  2020-11-25       Impact factor: 6.860

3.  Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status.

Authors:  Christopher E Jensen; Sanah N Vohra; Kirsten A Nyrop; Allison M Deal; Hyman B Muss; Eben I Lichtman; Samuel M Rubinstein; William A Wood; Nicholas J Mangieri; Lee Jamison; Shakira J Grant; Sascha A Tuchman
Journal:  J Geriatr Oncol       Date:  2021-08-11       Impact factor: 3.929
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.